Skip to main content

MoneyWorks4Me

Rubicon Research informs about grant of stock options

05 Nov 2026 Evaluate
Rubicon Research has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company had on, November 4, 2026, approved the grant in terms of Rubicon Research Limited Stock Option Plan 2026. The brief general terms and conditions of the said Grant are enclosed.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..